Starpharma – executive interview

Starpharma — 1 video in collection

In this video we speak with Cheryl Maley, CEO of Starpharma, an Australian biotechnology company with two decades of experience in advancing dendrimer technologies from the lab to the patient. In this interview, Cheryl covers what makes Starpharma’s dendrimer technology platform unique, details of the company’s partnerships with Genentech and Radiopharm Theranostics, alongside its Star Navigator programme. She also provides a rundown of Starpharma’s internal programmes focussed on oncology, before concluding with key milestones and catalysts for investors to watch out for.

< Previous

You may also be interested in these:

Healthcare

02.12.25

CHOSA Oncology – executive interview

Healthcare

02.12.25

Equities

Equities by Sector

Sectors

Thematics

Latest

The plan to deliver $4–5bn in cost savings is central to bp’s renewed strategy. Is it realistic?

Deep dive into bp’s case for income investment

The bull case deep dive: A closer look at bp’s cash flows

Audiovisual

Latest